Are You on My List?
January 26, 2021
Everything cell + gene therapy – in five minutes.
1 min read

January 26, 2021
Everything cell + gene therapy – in five minutes.
1 min read
January 26, 2021
Mice with severed spinal cords walk again after gene therapy
1 min read
January 18, 2021
With pipelines diversifying, it’s time to take a long hard look at manufacturing to ensure that facilities are flexible enough to cope with multiple modalities – including cell and gene therapies.
1 min read
January 18, 2021
When it comes to virus and viral protein analysis, settling for “gold-standard methods” isn’t good enough. To navigate the roadblocks ahead of successful vaccine development, we must dig deep into the analytical armamentarium
1 min read
January 14, 2021
Sitting Down With… Warwick Smith, Director General of the British Manufacturing Generics Association, London, UK.
1 min read
January 13, 2021
Big Data opens the door to “smart” cell therapies that remain inert unless triggered by cancer-specific protein combinations
1 min read
January 12, 2021
Sitting Down With… David Lee, Global Immunology Therapeutic Area Head at Janssen Research & Development, LLC, Spring House, PA
1 min read
January 11, 2021
How has pharma’s ad spending changed in 2020?
1 min read
January 7, 2021
The cell and gene therapy industry remains strong at the end of a difficult year – according to industry experts in The Medicine Maker 2020 Cell and Gene Therapy Supplement.
1 min read
January 7, 2021
The cell and gene therapy industry remains strong at the end of a difficult year – according to industry experts in The Medicine Maker 2020 Cell and Gene Therapy Supplement.
1 min read
False
False